Montreal-based Knight Therapeutics has galloped in with CAD $120 million ($84 million) to pick up Endo’s Paladin Pharma unit in a move that stands to significantly expand its Canadian business. | The ...

In addition, Knight may pay future contingent payments of up to US$15 million upon achieving certain sales milestones. In 2024, Paladin generated revenues of $70 million excluding products that ...

War rages between Accord and Ascension with Boss Fight Studio’s Hero H.A.C.K.S. series as they debut new 1/18 scale figure ...

Davies Ward Phillips & Vineberg LLP; Paladin Pharma Inc. Knight Therapeutics Inc. has entered into a definitive Asset Purchase Agreement (“APA”) with Endo Operations Limited (“Endo”) and Paladin ...